HHS-OIG – Policy & Medicine

HHS OIG Reviews FDA’s Accelerated Approval of Aducanumab

HHS OIG Releases Semiannual Report to Congress

HHS OIG Report Finds that CMS Made Additional Risk-Adjusted Payments Related to Health Risk Assessments

Arizona Couple Pleads Guilty in Massive $1.2 Billion Healthcare Fraud Scheme

Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs: Complaint included Significant Open Payments Under Reporting

HHS OIG Releases Report on Compliance with Hospital Price Transparency Rule

Announcing the Launch of the This Week in Policy and Medicine Podcast

HHS OIG’s Mary Riordan Outlines New Compliance Priorities at Compliance Congress

HHS OIG Says Humana Received More than $13 Million in CMS Overpayments in 2017 and 2018

HHS OIG Issues Favorable Advisory Opinion Regarding Patient Assistance Programs